Correlation Between Hookipa Pharma and Chimerix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hookipa Pharma and Chimerix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hookipa Pharma and Chimerix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hookipa Pharma and Chimerix, you can compare the effects of market volatilities on Hookipa Pharma and Chimerix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hookipa Pharma with a short position of Chimerix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hookipa Pharma and Chimerix.

Diversification Opportunities for Hookipa Pharma and Chimerix

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between Hookipa and Chimerix is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and Chimerix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chimerix and Hookipa Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hookipa Pharma are associated (or correlated) with Chimerix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chimerix has no effect on the direction of Hookipa Pharma i.e., Hookipa Pharma and Chimerix go up and down completely randomly.

Pair Corralation between Hookipa Pharma and Chimerix

Given the investment horizon of 90 days Hookipa Pharma is expected to under-perform the Chimerix. In addition to that, Hookipa Pharma is 1.77 times more volatile than Chimerix. It trades about -0.03 of its total potential returns per unit of risk. Chimerix is currently generating about 0.01 per unit of volatility. If you would invest  97.00  in Chimerix on August 25, 2024 and sell it today you would lose (7.00) from holding Chimerix or give up 7.22% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy99.66%
ValuesDaily Returns

Hookipa Pharma  vs.  Chimerix

 Performance 
       Timeline  
Hookipa Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hookipa Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Chimerix 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Chimerix has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Chimerix is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Hookipa Pharma and Chimerix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hookipa Pharma and Chimerix

The main advantage of trading using opposite Hookipa Pharma and Chimerix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hookipa Pharma position performs unexpectedly, Chimerix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chimerix will offset losses from the drop in Chimerix's long position.
The idea behind Hookipa Pharma and Chimerix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world